Company: TIPT
Filing Date: 2025-10-31
Form Type: DEFM14A
Source: 0001140361-25-039949
Chunk: 157

Company: TIPTREE INC.
Filing Date: 2025-10-31
Form: DEFM14A
Chunk 157
---
 is terminated in accordance with its terms, except as otherwise set forth in the applicable section of the disclosure schedule, as required by applicable law (including tax laws), any Permitted Leakage or with the prior written consent of Purchaser, which consent may not be unreasonably withheld, delayed or conditioned and will be deemed to have been provided if not affirmatively withheld or granted within 15 business days of Fortegra’s request therefor, Fortegra is required not to, and Fortegra is required to cause each of its Subsidiaries not to:

| • | amend, restate or otherwise modify (or waive provisions in) the organizational documents of Fortegra or, in any material respect, the other Group Companies; |

| • | issue, reissue, sell, transfer or pledge, or authorize, permit or propose the issuance, reissuance, sale, transfer, change of ownership or pledge of, shares of capital stock of any class or series, or any securities convertible into capital stock of any class or series of Fortegra or any Subsidiary or other equity interests of any Group Company, or grant or enter into any equity interests or amend any terms of any such equity interest except, in each case: (i) pursuant to contractual obligations existing on the date of the Merger Agreement or in the |

81

TABLE OF CONTENTS

ordinary course of business and disclosed in the applicable section of the disclosure schedule, (ii) issuance and/or withholding of shares of Fortegra common stock in connection with the exercise, vesting and/or settlement of Fortegra equity awards or (iii) for transactions solely between or among Fortegra and any Subsidiary;

| • | declare, set aside or pay any dividend or other distribution of assets or other equity interests in respect of any class or series of its capital stock or other equity interests, other than (i) dividends and distributions by a Subsidiary to Fortegra or to a wholly owned Subsidiary of Fortegra in the ordinary course of business and (ii) as required by the agreements evidencing the grant of Fortegra equity awards outstanding on the date of the Merger Agreement or as otherwise permitted pursuant to the terms of the Merger Agreement; |

| • | adjust, split, combine, subdivide, reclassify or make any like change in any equity interest of Fortegra except for any anti-dilution adjustments to the Fortegra warrants pursuant to their terms (but not any issuance of an equity interest that would trigger any such anti-dil